canthaxanthin has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, DS; Odeleye, OE; Watson, RR | 1 |
| Chen, GJ; Huang, DS; Watson, RR; Watzl, B | 1 |
2 other study(ies) available for canthaxanthin and B16 Melanoma
| Article | Year |
|---|---|
Inhibitory effects of canthaxanthin on in vitro growth of murine tumor cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Analysis of Variance; Animals; Canthaxanthin; Cell Division; Cell Line, Transformed; Cells, Cultured; Fibrosarcoma; Melanoma, Experimental; Mice; Sarcoma, Experimental; Tumor Cells, Cultured | 1992 |
The effects of canthaxanthin on JB/MS melanoma growth during retroviral pathogenesis induced by LP-BM5 murine leukemia virus.
Topics: Acquired Immunodeficiency Syndrome; Animals; Body Weight; Canthaxanthin; Cytokines; Disease Models, Animal; Female; Fibrosarcoma; Graft Rejection; Immunocompetence; Interferon-gamma; Leukemia Virus, Murine; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Murine Acquired Immunodeficiency Syndrome; Neoplasm Transplantation; Organ Size; Spleen | 1991 |